Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Treatment of Post Traumatic Knee Osteoarthritis With Extracorporeal Shockwave Therapy

NCT: NCT06686680 · RECRUITING

NCT IDNCT06686680
StatusRECRUITING
Start Date2025-04-01
Completion2027-12
SponsorSpaulding Rehabilitation Hospital (OTHER)
First posted
Last updated

Brief Summary

This study is recruiting current or former athletes who had ACL reconstruction surgery over a year ago and have been diagnosed with knee osteoarthritis (OA). We are doing the research to investigate the effects of extracorporeal shockwave therapy (ESWT) on pain, function, biomechanics, knee range of motion and strength, inflammation, and joint structure and integrity of the knee.

Frequently Asked Questions

What is Treatment of Post Traumatic Knee Osteoarthritis With Extracorporeal Shockwave Therapy?

Treatment of Post Traumatic Knee Osteoarthritis With Extracorporeal Shockwave Therapy is a clinical trial registered under NCT06686680. Current status: RECRUITING.

What is the status of NCT06686680?

The current status of NCT06686680 (Treatment of Post Traumatic Knee Osteoarthritis With Extracorporeal Shockwave Therapy) is: RECRUITING.

When did Treatment of Post Traumatic Knee Osteoarthritis With Extracorporeal Shockwave Therapy start?

Treatment of Post Traumatic Knee Osteoarthritis With Extracorporeal Shockwave Therapy started on 2025-04-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑